ÂÜÀòÂÒÂ×

Mr. Ostrowski (b. 1972) is a Non-Executive Director of Faron Pharmaceuticals Ltd., a role he has served since joining the board in April 2022. He is a veteran biotech and financial executive with significant fundraising and investment bank experience.

Mr. Ostrowski is currently the Chief Financial Officer and Treasurer of AVROBIO (Nasdaq: AVRO), a role he has served since joining the company in January 2019. Prior to joining AVROBIO, he served as CFO of Summit Therapeutics plc. (Nasdaq: SMMT) and vice president of finance at Organogenesis Inc. (Nasdaq: ÂÜÀòÂÒÂ×O). He previously worked in investment banking, most recently as a director with Leerink Partners LLC. Having begun his career as an accountant with Coopers & Lybrand (now PricewaterhouseCoopers).

Mr. Ostrowski received a BS in accounting and economics from Babson College and an MBA from the University of Chicago Booth School of Business.

Holdings in the company: 2,009 shares and 30,000 stock options, entitling to the same amount of shares in the company.